Maureen Deehan
Chief Executive Officer at Vivtex Corp.
Profile
Maureen Deehan is currently the Chief Executive Officer at Vivtex Corp.
She previously worked at Nordic Nanovector ASA as the Head of Corporate Development & Strategy.
She completed her undergraduate degree at the University of Strathclyde and holds a doctorate from the University of Glasgow School of Medicine.
Maureen Deehan active positions
| Companies | Position | Start |
|---|---|---|
| Vivtex Corp. | Chief Executive Officer | 20/02/2023 |
Former positions of Maureen Deehan
| Companies | Position | End |
|---|---|---|
| THOR MEDICAL | Corporate Officer/Principal | - |
Training of Maureen Deehan
| University of Strathclyde | Undergraduate Degree |
| University of Glasgow School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Vivtex Corp. |
- Stock Market
- Insiders
- Maureen Deehan
